賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白
Recombinant Lysyl Oxidase Like Protein 2 (LOXL2)
LOR2; WS9-14; Lysyl oxidase homolog 2; Lysyl oxidase-related protein 2; Lysyl oxidase-related protein WS9-14
- 編號(hào)RPF552Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌, 細(xì)胞外基質(zhì)
- 預(yù)測(cè)分子量12.5kDa
- 實(shí)際分子量15kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Gln323~Pro427 with N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)5.9
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1200 ¥ 3000 ¥ 6000 ¥ 18000 ¥ 45000
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPF552Hu01 | 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPF552Hu02 | 賴氨酰氧化酶樣蛋白2(LOXL2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAF552Hu01 | 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體 | WB; IHC; ICC; IP. |
PAF552Hu02 | 賴氨酰氧化酶樣蛋白2(LOXL2)多克隆抗體 | WB; IHC; ICC; IP. |
SEF552Hu | 賴氨酰氧化酶樣蛋白2(LOXL2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMF552Hu | 賴氨酰氧化酶樣蛋白2(LOXL2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
BMC Cancer. | Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.12 [Pubmed: 24007603] |
Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells [Pubmed: 22966818] |
Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-? Levels and LOXL1 Genotype in Pseudoexfoliation [Pubmed:27116380] |
BMC Cancer | Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study [Pubmed:29558905] |
Laryngoscope | Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma [Pubmed: 31219623] |
留言咨詢